Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Nulojix – Treatment for Preventing Acute Organ Rejection Post Kidney Transplantation

Nulojix (Belatacept) was developed by Bristol Myers Squibb and is indicated to prevent the rejection of the organ in patients who have undergone kidney transplantation.

Go Top